Sign up for our daily briefing

Make your busy days simpler with the Axios AM and PM newsletters. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to the Axios Closer newsletter for insights into the day’s business news and trends and why they matter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with the Axios Sports newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with the Axios Des Moines newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with the Axios Tampa Bay newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

President Trump speaks during the daily briefing on the novel coronavirus. Photo: JIM WATSON / Getty Images

General Motors is exploring how it can help a small ventilator manufacturer ramp up production, but it is unlikely to make medical equipment itself as part of a broader wartime response to the novel coronavirus, as President Trump suggested Friday.

Why it matters: While GM CEO Mary Barra offered the automaker's help in fighting the global pandemic, the company is scrambling to keep up with the president's public statements. But it is wrong to assume that automakers can quickly retool industrial factories to make precision medical equipment the way they made bombs, tanks and airplanes during World War II.

Driving the news: At a press briefing Friday, Trump was asked if he could name any of the private companies that would manufacture medical supplies for the federal government under the Defense Production Act, which he invoked this week.

  • "I will be, but first I want to get approval. I assume they’d like it but I’ll let you know. One company that has openly stated it is General Motors," Trump responded to reporters' questions.

Reality check: GM has made no public commitment to produce medical supplies, but issued two statements, first on Wednesday and again late Friday to try to keep up with the Trump administration's public remarks.

Where it stands: GM said Friday evening it is collaborating with Ventec Life Systems, a manufacturer of an innovative multi-function ventilator, to see how it can help them increase production.

  • Ventec's product, approved by the FDA in 2017, combines five respiratory functions into a single, portable device that reduces the space, staff and supplies needed to manage patients on a ventilator.

What they're saying:  

  • Barra, in a statement: “We are working closely with Ventec to rapidly scale up production of their critically important respiratory products to support our country’s fight against the COVID-19 pandemic. We will continue to explore ways to help in this time of crisis.”
  • Chris Kiple, CEO, Ventec Life Systems, emailed Axios: "Ventilator manufacturers produce thousands of ventilators; auto manufactures produce millions of automobiles — they understand how to scale manufacturing and could be a helpful resource to expedite ventilator production.”

What's really happening:

  • On Thursday, a small team of senior manufacturing executives from GM flew to Seattle, and on Friday morning they visited Ventec's manufacturing facility in suburban Bothell, Wash., to learn about their product and manufacturing processes.

Their focus is on how GM can leverage its manufacturing expertise to help Ventec squeeze out more ventilators, according to a GM source.

  • There are no plans for GM to manufacture ventilators or parts for Ventec.
  • More likely, GM could use its global scale to lean on suppliers, including raw materials suppliers, to provide the components that Ventec needs.
  • It could also offer its expertise in mass production techniques to optimize Ventec's assembly processes.

One of the biggest challenges is securing components, especially the disposable, single-use tubes and masks made of highly specialized medical-grade materials, experts say.

  • Most are manufactured outside the U.S. — in Costa Rica, Japan, South Korea and China — and the virus has slowed production in many parts of the world.
  • Even where factories are producing ventilator parts, shipping is complicated by a drastic reduction in cargo carriers and air freight.
  • GM could potentially use its logistics networks to get those parts delivered to Ventec's facility faster.

Yes, but: There are many reasons why it's not feasible for an auto manufacturer to quickly retool a factory for ventilator production.

  • GM — or any experienced manufacturer — says it could easily 3D-print needed parts like valves as long as it had the math formulas, for example.
  • But getting clearance from the U.S. Food & Drug Administration is a giant hurdle.
  • The FDA must validate any new manufacturing facility for products like respiratory devices, a process that can take months or even years.

The bottom line: All options are on the table, says GM.

Go deeper

Reports: CIA finds "Havana Syndrome" unlikely caused by foreign campaign

CIA Director William Burns testifies during a Senate hearing on Capitol Hill last April. Photo: Saul Loeb-Pool/Getty Images

A preliminary CIA report rules out a foreign global campaign as the cause of American and Canadian diplomats affected by a mysterious illness known as "Havana syndrome," per multiple reports.

Why it matters: Some lawmakers had suggested the sometimes debilitating illness was due to directed energy attacks. But CIA officials told the New York Times that most of the 1,000 cases reported to the government could be "explained by environmental causes, undiagnosed medical conditions or stress." This finding has angered some victims, per the NYT.

Jan. 6 panel subpoenas 2 far-right "America First" activists

The House panel investigating the Capitol riot, from left; Reps. Bennie Thompson, Liz Cheney, Adam Kinzinger and Jamie Raskin on Capitol Hill in December. Photo: Drew Angerer/Getty Images

The House select committee investigating the Capitol riot issued subpoenas Wednesday for far-right leaders Nick Fuentes and Patrick Casey, who allegedly encouraged followers to go to D.C. and challenge the 2020 election results.

Why it matters: The action underscores the panel's increasing focus on rallies held ahead of the Capitol attack and how extremists were drawn to former President Trump's baseless claims of widespread voter fraud, per the New York Times.

Democrats fail to change Senate rules to pass voting rights bill

Senate Majority Leader during a news conference in Washington, D.C., on Wednesday. Photo: Alex Wong/Getty Images

Democrats failed Wednesday night to change Senate filibuster rules to pass the voting rights bill, with Sens. Joe Manchin (D-W.Va.) and Kyrsten Sinema (D-Ariz.) voting with Republicans.

The big picture: The failed effort came after Senate Republicans blocked the voting rights measure from coming to a final vote earlier Wednesday.